Related Experiment Video
Updated: Jul 4, 2026
06:40
Cost-Efficient Transcriptomic-Based Drug Screening
Published on: February 23, 2024
Economic evaluation of pharmacogenetic tests
1Department of Ambulatory Care and Prevention, Harvard Medical School and Children's Hospital, Boston, Massachusetts, USA. ann.wu@childrens.harvard.edu
Clinical Pharmacology and Therapeutics
|June 27, 2008
Summary
Pharmacogenetics uses genetic variation to predict patient response to medications, enabling personalized medicine. This approach optimizes treatment outcomes and guides drug development by predicting efficacy and adverse events.
Area of Science:
- Genomics
- Pharmacology
- Translational Medicine
Background:
- The completion of the human genome sequence has spurred advancements in predicting drug responses based on genetic variations.
- Pharmacogenetics investigates how individual genetic differences influence medication efficacy and toxicity.
- Personalized medicine aims to tailor healthcare decisions to a patient's unique genetic profile for optimal health outcomes.
Purpose of the Study:
- To explore the role of pharmacogenetics in predicting medication response.
- To highlight the potential of pharmacogenetics in achieving personalized medicine.
- To outline the applications of pharmacogenetic testing in clinical practice and drug development.
Main Methods:
- Review of current literature on pharmacogenetics and its applications.
- Analysis of the potential impact of genetic variation on drug response.
- Discussion of the utility of pharmacogenetic tests in clinical decision-making.
Main Results:
- Genetic variation significantly impacts individual responses to medications.
- Pharmacogenetic tests can predict both intended therapeutic effects and unintended adverse events.
- Dose titration and novel therapeutic development can be informed by pharmacogenetic data.
Conclusions:
- Pharmacogenetics is a key discipline for advancing personalized medicine.
- Genetic insights enable more precise and effective medication management.
- Pharmacogenetic testing offers a powerful tool for optimizing patient care and drug discovery.
Related Concept Videos
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...